Stocks in the Biotechnology Industry

Sector: Healthcare


Symbol Grade Name
ABCL F AbCellera Biologics Inc.
ABCM F Abcam plc
ABEO D Abeona Therapeutics Inc.
ABIO D ARCA biopharma, Inc.
ABUS D Arbutus Biopharma Corporation
ACAD D ACADIA Pharmaceuticals Inc.
ACER C Acer Therapeutics Inc.
ACET F Adicet Bio, Inc.
ACHL F Achilles Therapeutics plc
ACHV F Achieve Life Sciences, Inc.
ACIU C AC Immune SA
ACOR D Acorda Therapeutics, Inc.
ACRS F Aclaris Therapeutics, Inc.
ACST C Acasti Pharma, Inc.
ADAG C Adagene Inc.
ADAP F Adaptimmune Therapeutics plc
ADCT F ADC Therapeutics SA
ADIL C Adial Pharmaceuticals, Inc
ADMA D ADMA Biologics Inc
ADPT F Adaptive Biotechnologies Corporation
ADTX C ADiTx Therapeutics, Inc.
ADVM F Adverum Biotechnologies, Inc.
ADXS F Advaxis, Inc.
AEZS D AEterna Zentaris Inc.
AFMD F Affimed Therapeutics B.V.
AGE F AgeX Therapeutics, Inc.
AGEN B Agenus Inc.
AGIO A Agios Pharmaceuticals, Inc.
AGLE F Aeglea BioTherapeutics, Inc.
AGTC D Applied Genetic Technologies Corporation
AIKI D AIkido Pharma Inc.
AIM C AIM ImmunoTech Inc.
AKBA C Akebia Therapeutics, Inc.
AKRO B Akero Therapeutics, Inc.
AKTX F Akari Therapeutics Plc
AKUS F Akouos, Inc.
ALBO C Albireo Pharma, Inc.
ALDX D Aldeyra Therapeutics, Inc.
ALEC B Alector, Inc.
ALGS C Aligos Therapeutics, Inc.
ALKS A Alkermes plc
ALLK F Allakos Inc.
ALLO F Allogene Therapeutics, Inc.
ALNA D Allena Pharmaceuticals, Inc.
ALNY B Alnylam Pharmaceuticals, Inc.
ALPN F Alpine Immune Sciences, Inc.
ALRN D Aileron Therapeutics, Inc.
ALT C Altimmune, Inc.
ALVR F AlloVir, Inc.
ALXN A Alexion Pharmaceuticals, Inc.
ALXO F ALX Oncology Holdings Inc.
AMPE C Ampio Pharmaceuticals, Inc.
AMRN D Amarin Corporation plc
AMTI B Applied Molecular Transport Inc.
ANAB B AnaptysBio, Inc.
ANEB F Anebulo Pharmaceuticals, Inc.
ANGN F Angion Biomedica Corp.
ANIK D Anika Therapeutics Inc.
ANIP C ANI Pharmaceuticals, Inc.
ANNX C Annexon, Inc.
ANPC F AnPac Bio-Medical Science Co., Ltd.
ANVS B Annovis Bio, Inc.
APLS B Apellis Pharmaceuticals, Inc.
APLT C Applied Therapeutics, Inc.
APM D Aptorum Group Limited
APOP C Cellect Biotechnology Ltd.
APRE D Aprea Therapeutics, Inc.
APTO F Aptose Biosciences, Inc.
APTX C Aptinyx Inc.
APVO C Aptevo Therapeutics Inc.
AQB D AquaBounty Technologies, Inc.
AQST D Aquestive Therapeutics, Inc.
ARAV F Aravive, Inc.
ARCT F Arcturus Therapeutics Ltd.
ARDS B Aridis Pharmaceuticals Inc.
ARDX D Ardelyx, Inc.
ARGX B argenx SE
ARMP C Armata Pharmaceuticals, Inc.
ARNA D Arena Pharmaceuticals, Inc.
ARPO B Aerpio Pharmaceuticals, Inc.
ARQT D Arcutis Biotherapeutics, Inc.
ARTL F Artelo Biosciences, Inc.
ARVN B Arvinas, Inc.
ARWR B Arrowhead Research Corporation
ASLN C ASLAN Pharmaceuticals Limited
ASMB F Assembly Biosciences, Inc.
ASND D Ascendis Pharma A/S
ATHA D Athira Pharma, Inc.
ATHE D Alterity Therapeutics Limited
ATHX F Athersys, Inc.
ATNM D Actinium Pharmaceuticals, Inc.
ATNX D Athenex, Inc.
ATRA D Atara Biotherapeutics, Inc.
AUPH D Aurinia Pharmaceuticals Inc
AUTL D Autolus Therapeutics plc
AVDL F Avadel Pharmaceuticals plc
AVEO F AVEO Pharmaceuticals, Inc.
AVIR F Atea Pharmaceuticals, Inc.
AVRO F AVROBIO, Inc.
AVXL B Anavex Life Sciences Corp.
AXLA C Axcella Health Inc.
AXSM C Axsome Therapeutics, Inc.
AYLA F Ayala Pharmaceuticals, Inc.
AYTU F Aytu BioScience, Inc.
AZRX D AzurRx BioPharma, Inc.
BBI F Brickell Biotech, Inc.
BBIO B BridgeBio Pharma, Inc.
BCAB F BioAtla, Inc.
BCDA C BioCardia, Inc.
BCEL F Atreca, Inc.
BCLI D Brainstorm Cell Therapeutics Inc.
BCRX C BioCryst Pharmaceuticals, Inc.
BCTX B BriaCell Therapeutics Corp.
BCYC D Bicycle Therapeutics plc
BDSI D BioDelivery Sciences International, Inc.
BDTX F Black Diamond Therapeutics, Inc.
BEAM C Beam Therapeutics Inc.
BFRA D Biofrontera AG
BGNE C BeiGene, Ltd.
BHVN C Biohaven Pharmaceutical Holding Company Ltd.
BIVI D BioVie Inc.
BLCM F Bellicum Pharmaceuticals, Inc.
BLI F Berkeley Lights, Inc.
BLPH D Bellerophon Therapeutics, Inc.
BLRX F BioLineRx Ltd.
BLU F BELLUS Health Inc.
BLUE D bluebird bio, Inc.
BMEA C Biomea Fusion, Inc.
BMRN B BioMarin Pharmaceutical Inc.
BNTX C BioNTech SE
BOLT F Bolt Biotherapeutics, Inc.
BPMC F Blueprint Medicines Corporation
BPTS F Biophytis SA
BTAI D BioXcel Therapeutics, Inc.
BVXV F BiondVax Pharmaceuticals Ltd.
BXRX F Baudax Bio, Inc.
BYSI D BeyondSpring, Inc.
CABA F Cabaletta Bio, Inc.
CALA D Calithera Biosciences, Inc.
CANF C Can-Fite Biopharma Ltd Sponsored ADR (Israel)
CAPR D Capricor Therapeutics, Inc.
CARA F Cara Therapeutics, Inc.
CATB F Catabasis Pharmaceuticals, Inc.
CBAY D CymaBay Therapeutics Inc.
CBIO F Catalyst Inc.
CBLI D Cleveland BioLabs, Inc.
CBMG A Cellular Biomedicine Group, Inc.
CBPO A China Biologic Products, Inc.
CCXI F ChemoCentryx, Inc.
CDAK C Codiak BioSciences, Inc.
CDMO A Avid Bioservices, Inc.
CDMOP D Avid Bioservices, Inc. - 10.50% Series E Convertible Preferred Stock
CDTX F Cidara Therapeutics, Inc.
CDXC C ChromaDex Corporation
CDXS F Codexis, Inc.
CERC B Cerecor Inc.
CERS F Cerus Corporation
CERT F Certara, Inc.
CFRX D ContraFect Corporation
CGEN F Compugen Ltd.
CHMA C Chiasma, Inc.
CHRS D Coherus BioSciences, Inc.
CKPT D Checkpoint Therapeutics, Inc.
CLBS D Caladrius Biosciences, Inc.
CLDX C Celldex Therapeutics, Inc.
CLGN B CollPlant Holdings, Ltd.
CLLS F Cellectis S.A.
CLRB F Cellectar Biosciences, Inc.
CLSD B Clearside Biomedical, Inc.
CLSN C Celsion Corporation
CLVS D Clovis Oncology, Inc.
CMMB F ChemomAb Therapeutics Ltd.
CMPI F Checkmate Pharmaceuticals, Inc.
CMRX D Chimerix, Inc.
CNCE D Concert Pharmaceuticals, Inc.
CNSP F CNS Pharmaceuticals, Inc.
CNST C Constellation Pharmaceuticals, Inc.
CNTA C Centessa Pharmaceuticals plc
CNTB B Connect Biopharma Holdings Limited
CO C China Cord Blood Corporation
COCP D Cocrystal Pharma, Inc.
COGT D Cogent Biosciences, Inc.
CORT C Corcept Therapeutics Incorporated
CRBP C Corbus Pharmaceuticals Holdings, Inc.
CRIS F Curis, Inc.
CRMD C CorMedix Inc
CRNX B Crinetics Pharmaceuticals, Inc.
CRSP D CRISPR Therapeutics AG
CRTX B Cortexyme, Inc.
CRVS D Corvus Pharmaceuticals, Inc.
CSBR F Champions Oncology, Inc.
CTIC F Cell Therapeutics, Inc.
CTMX F CytomX Therapeutics, Inc.
CTXR A Citius Pharmaceuticals, Inc.
CUE D Cue Biopharma, Inc.
CVAC F CureVac N.V.
CVM C Cel-Sci Corporation
CWBR C CohBar, Inc.
CYAD F Celyad SA
CYCC F Cyclacel Pharmaceuticals, Inc.
CYCCP C Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
CYCN D Cyclerion Therapeutics, Inc.
CYTH C Cyclo Therapeutics, Inc.
CYTK D Cytokinetics, Incorporated
DARE F Dare Bioscience, Inc.
DAWN F Day One Biopharmaceuticals, Inc.
DBTX D Decibel Therapeutics, Inc.
DBVT C DBV Technologies S.A.
DCPH F Deciphera Pharmaceuticals, Inc.
DFFN D Diffusion Pharmaceuticals Inc.
DMAC F DiaMedica Therapeutics Inc.
DNLI B Denali Therapeutics Inc.
DRNA B Dicerna Pharmaceuticals, Inc.
DSGN C Design Therapeutics, Inc.
DTIL C Precision BioSciences, Inc.
DVAX F Dynavax Technologies Corporation
DYAI F Dyadic International, Inc.
EARS C Auris Medical Holding AG
EBS F Emergent Biosolutions, Inc.
EDIT F Editas Medicine, Inc.
EDSA F Edesa Biotech, Inc.
EIDX C Eidos Therapeutics, Inc.
EIGR F Eiger BioPharmaceuticals, Inc.
ELDN F Eledon Pharmaceuticals, Inc.
ELOX F Eloxx Pharmaceuticals, Inc.
ENLV F Enlivex Therapeutics Ltd.
ENOB C Enochian Biosciences, Inc.
ENTA F Enanta Pharmaceuticals, Inc.
ENTX C Entera Bio Ltd.
EPZM D Epizyme, Inc.
EQ F Equillium, Inc.
ERYP F Erytech Pharma S.A.
ESPR D Esperion Therapeutics, Inc.
ETNB F 89bio, Inc.
ETON F Eton Pharmaceutcials, Inc.
EVAX C Evaxion Biotech A/S
EVFM F Evofem Biosciences, Inc.
EVGN F Evogene
EVLO B Evelo Biosciences, Inc.
EWTX F Edgewise Therapeutics, Inc.
EXEL F Exelixis, Inc.
EYEG D Eyegate Pharmaceuticals, Inc.
EYEN B Eyenovia, Inc.
EYPT C EyePoint Pharmaceuticals, Inc.
FATE B Fate Therapeutics, Inc.
FBIO F Fortress Biotech, Inc.
FBIOP C Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
FBRX C Forte Biosciences, Inc.
FDMT F 4D Molecular Therapeutics, Inc.
FENC F Fennec Pharmaceuticals Inc.
FGEN D FibroGen, Inc
FHTX C Foghorn Therapeutics Inc.
FIXX D Homology Medicines, Inc.
FMTX F Forma Therapeutics Holdings, Inc.
FNCH D Finch Therapeutics Group, Inc.
FOLD D Amicus Therapeutics, Inc.
FPRX B Five Prime Therapeutics, Inc.
FREQ F Frequency Therapeutics, Inc.
FRLN F Freeline Therapeutics Holdings plc
FSTX D F-star Therapeutics, Inc.
FULC F Fulcrum Therapeutics, Inc.
FUSN F Fusion Pharmaceuticals Inc.
FWP C Forward Pharma A/S
GANX F Gain Therapeutics, Inc.
GBIO F Generation Bio Co.
GBT F Global Blood Therapeutics, Inc.
GERN F Geron Corporation
GLMD D Galmed Pharmaceuticals Ltd.
GLPG F Galapagos NV
GLSI C Greenwich LifeSciences, Inc.
GLTO D Galecto, Inc.
GLYC D GlycoMimetics, Inc.
GMDA F Gamida Cell Ltd.
GMTX D Gemini Therapeutics, Inc.
GNCA F Genocea Biosciences, Inc.
GNFT F GENFIT S.A.
GNPX F Genprex, Inc.
GOSS D Gossamer Bio, Inc.
GOVX B GeoVax Labs, Inc.
GRAY D Graybug Vision, Inc.
GRCL C Gracell Biotechnologies Inc.
GRTS C Gritstone Oncology, Inc.
GRTX D Galera Therapeutics, Inc.
GTBP C GT Biopharma, Inc.
GTHX F G1 Therapeutics, Inc.
HALO D Halozyme Therapeutics, Inc.
HARP F Harpoon Therapeutics, Inc.
HEPA D Hepion Pharmaceuticals, Inc.
HGEN C Humanigen, Inc.
HOOK F HOOKIPA Pharma Inc.
HOTH D Hoth Therapeutics, Inc.
HOWL C Werewolf Therapeutics, Inc.
HRMY D Harmony Biosciences Holdings, Inc.
HSTO F Histogen Inc.
HTBX D Heat Biologics, Inc.
IBIO D iBio, Inc.
IBRX F ImmunityBio, Inc.
ICCC B ImmuCell Corporation
ICPT D Intercept Pharmaceuticals, Inc.
IDRA D Idera Pharmaceuticals, Inc.
IDYA B IDEAYA Biosciences, Inc.
IFRX F InflaRx N.V.
IGMS C IGM Biosciences, Inc.
IKNA F Ikena Oncology, Inc.
IKT F Inhibikase Therapeutics, Inc.
IMAB C I-Mab
IMCR D Immunocore Holdings plc
IMGN D ImmunoGen, Inc.
IMMP C Immutep Limited - American Depositary Shares
IMNM F Immunome, Inc.
IMPL F Impel NeuroPharma, Inc.
IMRA D IMARA Inc.
IMRN F Immuron Limited
IMTX C Immatics N.V.
IMUX F Immunic, Inc.
IMV F IMV Inc.
IMVT F Immunovant, Inc.
INBX C Inhibrx, Inc.
INCY D Incyte Corporation
INFI C Infinity Pharmaceuticals, Inc.
INM F InMed Pharmaceuticals Inc.
INMB C INmune Bio Inc.
INO D Inovio Pharmaceuticals, Inc.
INSM F Insmed, Inc.
INVA B Innoviva, Inc.
INZY F Inozyme Pharma, Inc.
IONS F Ionis Pharmaceuticals, Inc.
IOVA F Iovance Biotherapeutics, Inc.
IPA F ImmunoPrecise Antibodies Ltd.
IPHA F Innate Pharma S.A.
ISEE F IVERIC bio, Inc.
ITCI A Intra-Cellular Therapies Inc.
ITOS D iTeos Therapeutics, Inc.
ITRM B Iterum Therapeutics plc
IVA B Inventiva S.A.
JAGX C Jaguar Animal Health, Inc.
JAZZ A Jazz Pharmaceuticals plc
JNCE F Jounce Therapeutics, Inc.
KALA F Kala Pharmaceuticals, Inc.
KALV B KalVista Pharmaceuticals, Inc.
KDMN C Kadmon Holdings, Inc.
KDNY C Chinook Therapeutics, Inc.
KIN A Kindred Biosciences, Inc.
KLDO F Kaleido Biosciences, Inc.
KMDA F Kamada Ltd.
KMPH B KemPharm, Inc.
KNSA F Kiniksa Pharmaceuticals, Ltd.
KNTE F Kinnate Biopharma Inc.
KOD F Kodiak Sciences Inc
KRBP C Kiromic BioPharma, Inc.
KROS F Keros Therapeutics, Inc.
KRTX B Karuna Therapeutics, Inc.
KRYS F Krystal Biotech, Inc.
KTRA C Kintara Therapeutics, Inc.
KURA F Kura Oncology, Inc.
KYMR C Kymera Therapeutics, Inc.
KZIA D Kazia Therapeutics Limited
KZR F Kezar Life Sciences, Inc.
LABP C Landos Biopharma, Inc.
LBPH F Longboard Pharmaceuticals, Inc.
LBPS D 4D pharma plc
LCTX B Lineage Cell Therapeutics, Inc.
LEGN C Legend Biotech Corporation
LGND D Ligand Pharmaceuticals Incorporated
LIFE C aTyr Pharma, Inc.
LIXT C Lixte Biotechnology Holdings, Inc.
LJPC C La Jolla Pharmaceutical Company
LMNL F Liminal BioSciences Inc.
LOGC F LogicBio Therapeutics, Inc.
LPTX D LEAP THERAPEUTICS, INC.
LQDA F Liquidia Technologies, Inc.
LRMR F Larimar Therapeutics, Inc.
LTRN F Lantern Pharma Inc.
LUMO F Lumos Pharma, Inc.
LVTX F LAVA Therapeutics N.V.
LXRX C Lexicon Pharmaceuticals, Inc.
LYRA D Lyra Therapeutics, Inc.
MACK D Merrimack Pharmaceuticals, Inc.
MBIO C Mustang Bio, Inc.
MBRX D Moleculin Biotech, Inc.
MCRB F Seres Therapeutics, Inc.
MDGL F Madrigal Pharmaceuticals, Inc.
MDNA D Medicenna Therapeutics Corp.
MDWD C MediWound Ltd.
MESO D Mesoblast Limited
MGNX F MacroGenics, Inc.
MGTA D Magenta Therapeutics, Inc.
MGTX B MeiraGTx Holdings plc
MIRM D Mirum Pharmaceuticals, Inc.
MIST D Milestone Pharmaceuticals Inc.
MITO C Stealth BioTherapeutics Corp.
MLND D Millendo Therapeutics, Inc.
MNKD C MannKind Corporation
MNOV F MediciNova, Inc.
MNPR C Monopar Therapeutics Inc.
MOR F MorphoSys AG
MORF B Morphic Holding, Inc.
MREO F Mereo BioPharma Group plc
MRKR B Marker Therapeutics, Inc.
MRNA C Moderna, Inc.
MRNS B Marinus Pharmaceuticals, Inc.
MRSN F Mersana Therapeutics, Inc.
MRTX D Mirati Therapeutics, Inc.
MRUS D Merus N.V.
MRVI A Maravai LifeSciences Holdings, Inc.
MTCR C Metacrine, Inc.
MTEM F Molecular Templates, Inc.
MTNB D Matinas Biopharma Holdings, Inc.
MTP F Midatech Pharma PLC
MYOV C Myovant Sciences Ltd.
NAVB D Navidea Biopharmaceuticals, Inc.
NBIX C Neurocrine Biosciences, Inc.
NBRV F Nabriva Therapeutics AG
NBSE F NeuBase Therapeutics, Inc.
NBTX D Nanobiotix S.A.
NBY F NovaBay Pharmaceuticals, Inc.
NCNA F NuCana plc
NERV D Minerva Neurosciences, Inc
NEXI F NexImmune, Inc.
NGM F NGM Biopharmaceuticals, Inc.
NKTR F Nektar Therapeutics
NKTX F Nkarta, Inc.
NLSP F NLS Pharmaceutics Ltd.
NMTR B 9 Meters Biopharma, Inc.
NOVN D Novan, Inc.
NRBO F NeuroBo Pharmaceuticals, Inc.
NRIX C Nurix Therapeutics, Inc.
NSTG D NanoString Technologies, Inc.
NTEC F Intec Pharma Ltd.
NTLA C Intellia Therapeutics, Inc.
NVAX D Novavax, Inc.
NVIV F InVivo Therapeutics Holdings Corp.
NVO A Novo Nordisk A/S
NXTC F NextCure, Inc.
NYMX F Nymox Pharmaceutical Corporation
OBSV C ObsEva SA
OCGN F Ocugen, Inc.
OCUL F Ocular Therapeutix, Inc.
OCUP D Ocuphire Pharma, Inc.
OCX B OncoCyte Corporation
ODT F Odonate Therapeutics, Inc.
OGEN F Oragenics, Inc.
OLMA C Olema Pharmaceuticals, Inc.
OMER F Omeros Corporation
ONCR C Oncorus, Inc.
ONCS F OncoSec Medical Incorporated
ONCT F Oncternal Therapeutics, Inc.
ONCY F Oncolytics Biotech Inc.
ONTX F Onconova Therapeutics, Inc.
OPNT B Opiant Pharmaceuticals, Inc.
ORGS F Orgenesis Inc.
ORIC F Oric Pharmaceuticals, Inc.
ORMP B Oramed Pharmaceuticals Inc.
ORTX F Orchard Therapeutics plc
OSMT F Osmotica Pharmaceuticals plc
OTIC D Otonomy, Inc.
OTLK C Outlook Therapeutics, Inc.
OVID C Ovid Therapeutics Inc.
OYST F Oyster Point Pharma, Inc.
PALI F Palisade Bio, Inc.
PAND A Pandion Therapeutics Inc.
PASG F Passage Bio, Inc.
PBLA F Panbela Therapeutics, Inc.
PBYI D Puma Biotechnology Inc
PCSA F Processa Pharmaceuticals, Inc.
PCVX D Vaxcyte, Inc.
PDSB C PDS Biotechnology Corporation
PGEN F Precigen, Inc.
PHAS B PhaseBio Pharmaceuticals, Inc.
PHAT F Phathom Pharmaceuticals, Inc.
PHIO D Phio Pharmaceuticals Corp.
PHVS F Pharvaris N.V.
PIRS B Pieris Pharmaceuticals, Inc.
PLRX D Pliant Therapeutics, Inc.
PLX F Protalix BioTherapeutics, Inc.
PLXP C PLx Pharma Inc.
PMVP C PMV Pharmaceuticals, Inc.
PPBT C Purple Biotech Ltd.
PRAX F Praxis Precision Medicines, Inc.
PRLD F Prelude Therapeutics Incorporated
PROG F Progenity, Inc.
PRQR B ProQR Therapeutics B.V.
PRTA A Prothena Corporation plc
PRTC D PureTech Health plc
PRTG A Portage Biotech Inc.
PRTK C Paratek Pharmaceuticals, Inc.
PRVB F Provention Bio, Inc.
PRVL A Prevail Therapeutics Inc.
PSNL D Personalis, Inc.
PSTI F Pluristem Therapeutics, Inc.
PSTV C Plus Therapeutics, Inc.
PSTX D Poseida Therapeutics, Inc.
PTCT D PTC Therapeutics, Inc.
PTE C PolarityTE, Inc.
PTGX A Protagonist Therapeutics, Inc.
PTIX C Protagenic Therapeutics, Inc.
PTPI F Petros Pharmaceuticals, Inc.
PULM D Pulmatrix, Inc.
PYPD F PolyPid Ltd.
QLGN D Qualigen Therapeutics, Inc.
QTRX B Quanterix Corporation
QURE D uniQure N.V.
RAIN F Rain Therapeutics Inc.
RAPT B RAPT Therapeutics, Inc.
RARE F Ultragenyx Pharmaceutical Inc.
RCKT B Rocket Pharmaceuticals, Inc.
RCUS F Arcus Biosciences, Inc.
RDHL D Redhill Biopharma Ltd.
REGN B Regeneron Pharmaceuticals, Inc.
REPH F Recro Pharma, Inc.
REPL D Replimune Group, Inc.
RETA C Reata Pharmaceuticals, Inc. - Class A
RFL B Rafael Holdings, Inc.
RGEN D Repligen Corporation
RGLS F Regulus Therapeutics Inc.
RGNX B REGENXBIO Inc.
RIGL B Rigel Pharmaceuticals, Inc.
RLAY D Relay Therapeutics, Inc.
RNA C Avidity Biosciences, Inc.
RPHM F Reneo Pharmaceuticals, Inc.
RPRX D Royalty Pharma plc
RPTX B Repare Therapeutics Inc.
RUBY C Rubius Therapeutics, Inc.
RVMD D Revolution Medicines, Inc.
RVNC B Revance Therapeutics, Inc.
RVPH F Reviva Pharmaceuticals Holdings, Inc.
RXDX A Prometheus Biosciences, Inc.
RXRX C Recursion Pharmaceuticals, Inc.
RYTM F Rhythm Pharmaceuticals, Inc.
RZLT D Rezolute, Inc.
SAGE F Sage Therapeutics, Inc.
SANA D Sana Biotechnology, Inc.
SAVA B Cassava Sciences, Inc.
SBBP B Strongbridge Biopharma plc
SBTX D Silverback Therapeutics, Inc.
SCPH F scPharmaceuticals Inc.
SCPS F Scopus BioPharma Inc.
SEEL F Seelos Therapeutics, Inc.
SEER F Seer, Inc.
SELB B Selecta Biosciences, Inc.
SESN A Sesen Bio, Inc.
SGEN D Seattle Genetics, Inc.
SGMO D Sangamo BioSciences, Inc.
SGTX F Sigilon Therapeutics, Inc.
SIGA F SIGA Technologies Inc.
SIOX D Sio Gene Therapies Inc.
SLGL C Sol-Gel Technologies Ltd.
SLN C Silence Therapeutics Plc
SLRX F Salarius Pharmaceuticals, Inc.
SLS C SELLAS Life Sciences Group, Inc.
SNDX C Syndax Pharmaceuticals, Inc.
SNGX F Soligenix, Inc.
SNPX D Synaptogenix, Inc.
SNSE D Sensei Biotherapeutics, Inc.
SONN F SONNET BioTherapeutics, Inc.
SPPI B Spectrum Pharmaceuticals, Inc.
SPRB F Spruce Biosciences, Inc.
SPRO D Spero Therapeutics, Inc.
SQZ C SQZ Biotechnologies Company
SRNE D Sorrento Therapeutics, Inc.
SRPT D Sarepta Therapeutics, Inc.
SRRA B Sierra Oncology, Inc.
SRRK F Scholar Rock Holding Corporation
STOK D Stoke Therapeutics, Inc.
STRO F Sutro Biopharma, Inc.
STSA F Satsuma Pharmaceuticals, Inc.
SURF F Surface Oncology, Inc.
SVA F Sinovac Biotech, Ltd. (Antigua/Barbudo)
SVRA C Savara, Inc.
SWTX C SpringWorks Therapeutics, Inc.
SYBX B Synlogic, Inc.
SYN C Synthetic Biologics, Inc.
SYRS F Syros Pharmaceuticals, Inc.
TALS F Talaris Therapeutics, Inc.
TARA F ArTara Therapeutics, Inc.
TARS C Tarsus Pharmaceuticals, Inc.
TBIO C Translate Bio, Inc.
TBPH F Theravance Biopharma, Inc.
TCON F TRACON Pharmaceuticals, Inc.
TCRR F TCR2 Therapeutics Inc.
TECH A Techne Corporation
TENX C Tenax Therapeutics, Inc.
TERN F Terns Pharmaceuticals, Inc.
TFFP D TFF Pharmaceuticals, Inc.
TGTX F TG Therapeutics, Inc.
TIL F Instil Bio, Inc.
TLC C Taiwan Liposome Company, Ltd.
TLSA F Tiziana Life Sciences plc
TMBR F Timber Pharmaceuticals, Inc.
TNXP C Tonix Pharmaceuticals Holding Corp.
TPTX D Turning Point Therapeutics, Inc.
TRIL D Trillium Therapeutics Inc.
TRVI F Trevi Therapeutics, Inc.
TRVN D Trevena, Inc.
TSHA B Taysha Gene Therapies, Inc.
TTNP D Titan Pharmaceuticals, Inc.
TYME F Tyme Technologies, Inc.
UBX F Unity Biotechnology, Inc.
URGN F UroGen Pharma Ltd.
UROV A Urovant Sciences Ltd.
UTHR D United Therapeutics Corporation
VACC F Vaccitech plc
VALN F Valneva SE
VBIV C VBI Vaccines Inc.
VBLT C Vascular Biogenics Ltd.
VCEL B Vericel Corporation
VCNX D Vaccinex, Inc.
VCYT F Veracyte, Inc.
VIE F Viela Bio, Inc.
VINCU D Vincera Pharma, Inc. - Unit
VIR D Vir Biotechnology, Inc.
VIRI C Virios Therapeutics, Inc.
VIRX C Viracta Therapeutics, Inc.
VKTX D Viking Therapeutics, Inc.
VLON C Vallon Pharmaceuticals Inc.
VNDA B Vanda Pharmaceuticals Inc.
VOR F Vor Biopharma Inc.
VRCA C Verrica Pharmaceuticals Inc.
VRNA D Verona Pharma plc
VRPX D Virpax Pharmaceuticals, Inc.
VRTX F Vertex Pharmaceuticals Incorporated
VSTM B Verastem, Inc.
VTGN B VistaGen Therapeutics, Inc.
VTVT D vTv Therapeutics Inc.
VXRT C Vaxart, Inc.
VYGR D Voyager Therapeutics, Inc.
VYNE F VYNE Therapeutics Inc. - Common Stock
WINT D Windtree Therapeutics, Inc.
WVE D WAVE Life Sciences Ltd.
XBIO C Xenetic Biosciences, Inc.
XBIT F XBiotech Inc.
XCUR F Exicure, Inc.
XENE D Xenon Pharmaceuticals Inc.
XERS D Xeris Pharmaceuticals, Inc.
XFOR D X4 Pharmaceuticals, Inc.
XLRN C Acceleron Pharma Inc.
XNCR F Xencor, Inc.
XOMA F XOMA Corporation
XOMAO C XOMA Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
XTLB D XTL Biopharmaceuticals Ltd.
XXII C 22nd Century Group, Inc.
YMAB C Y-mAbs Therapeutics, Inc.
YMTX F Yumanity Therapeutics, Inc.
ZEAL F Zealand Pharma A/S
ZIOP F ZIOPHARM Oncology Inc
ZIVO F Zivo Bioscience, Inc.
ZLAB C Zai Lab Limited
ZNTL D Zentalis Pharmaceuticals, Inc.
ZSAN C Zosano Pharma Corporation
ZYME C Zymeworks Inc.
ZYNE B Zynerba Pharmaceuticals, Inc.

Recent Signals

Date Stock Signal Type
2021-06-16 AGE Fell Below 50 DMA Bearish
2021-06-16 AIM Upper Bollinger Band Walk Strength
2021-06-16 AMPE Fell Below 20 DMA Bearish
2021-06-16 AMPE 50 DMA Support Bullish
2021-06-16 ANVS New 52 Week High Strength
2021-06-16 ANVS New 52 Week Closing High Bullish
2021-06-16 ANVS Pocket Pivot Bullish Swing Setup

Recent News for Biotechnology Stocks

Date Stock Title
Jun 16 CVAC Dow Jones Futures: Federal Reserve Warns Market Rally, Goldman In Buy Range; Covid Vaccine Play CureVac Crashes
Jun 16 CVAC CureVac Shot Falls Short; Moderna Gets U.S. Order: Virus Update
Jun 16 CTXR Top 3 Penny Stocks to Buy Right Now for Your 2021 Summer Watchlist
Jun 16 CRBP Cannabis Stock Gainers And Losers From June 16, 2021
Jun 16 CVAC CureVac’s COVID vaccine candidate 47% effective, stock tanks
Jun 16 CVAC STSA, AXLA, CVAC and CRBP among after-hours movers
Jun 16 TECH El Salvador's Decision On Bitcoin Is 'Nonsensical' And Could 'Collapse The Economy,' Economist Says
Jun 16 CVAC CureVac plunges as Bill Gates-backed biotech shows below-par efficacy for COVID-19 vaccine candidate (updated)
Jun 16 CVAC CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV
Jun 16 PRVB SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Provention Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - PRVB
Jun 16 NEXI NexImmune to Present at the Raymond James 2021 Human Health Innovation Conference
Jun 16 STSA Satsuma shares surge on data from early-stage STS101 trial
Jun 16 TARS Tarsus Pharmaceuticals initiates early-stage TP-05 Lyme disease trial
Jun 16 SNPX Synaptogenix: The Next Big Thing In Alzheimer's
Jun 16 CLSD Why Opthea Stock Skyrocketed Today
Jun 16 NOVN Novan shares under pressure after proposing capital raise
Jun 16 STSA Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
Jun 16 TARS Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
Jun 16 MRKR Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference
Jun 16 NOVN Novan Announces Proposed Public Offering of Common Stock